Micreos BV
Micreos endolysin based technology is the world's first targeted antibacterial product, set to replace antibiotics. Killing only the unwanted bacteria - including antibiotic resistant strains - while preserving the beneficial bacteria.
Product News
Microbiology Product Areas
ClinicalNOTE: The products listed in this section may not be approved for clinical diagnostic use in your jurisdiction. You must assume these products are unregulated and therefore cannot be used for routine testing and reporting of results unless otherwise stated. | ||
| Antibiotic Resistance | Show all suppliers | |
| Microbiome | Show all suppliers | |
Food & Beverage | ||
| Microbiome | Show all suppliers | |
Get our eNewsletter
Over 7,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!
LATEST MICROBIOLOGY NEWS
- Watch Cyclone in Action and Automate Your Microbiology Quality Control
- AFNOR Validation for Bio-Rad’s iQ-Check Listeria Protocols
- QC and Inventory Management Solutions for Clinical Microbiology Labs
- Superbug Surcharge: The Economics of MDROs and HAIs
- INTEGRA Biosciences Partners with CleanHub to Prevent Plastic Pollution
- BIOFIRE® FILMARRAY® Tropical Fever (TF) Panel Receives FDA Clearance
- The Revised EN ISO 7704:2023 is Advancing Water Quality Analysis, Is Your Lab Keeping Up?
- Water Microbiology - a rapidmicrobiology Special Focus
- Coming Soon from MicronView
- Revolutionizing Legionella pneumophila Detection in Water Microbiology